DYN R&D Expenses
Dyne Therapeutics Inc · R&D Expenses
DYN R&D Expenses
Latest reported$445.71Mperiod ending
DYN TTM R&D Expenses ($0.00 → $445.71M)
TTM R&D Expenses
High-resolution chart · PNG
DYN r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 445,708,000 | |
| 392,775,000 | |
| 398,333,000 | |
| 384,707,000 | |
| 380,288,000 | |
| 343,315,000 | |
| 281,407,000 | |
| 258,446,000 | |
| 220,897,000 | |
| 217,764,000 | |
| 210,761,000 | |
| 185,107,000 | |
| 164,526,000 | |
| 152,060,000 | |
| 142,760,000 | |
| 151,871,000 | |
| 153,711,000 | |
| 130,919,000 | |
| 121,308,000 | |
| 101,105,000 | |
| 74,274,000 | |
| 57,736,000 | |
| 45,200,000 | |
| 27,361,000 | |
| 20,664,000 | |
| 15,229,500 | |
| 11,040,000 | |
| 6,781,000 | |
| 3,799,000 | |
| 1,899,500 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |